BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
When do Bupivacaine Hydrochloride Preservative Free patents expire, and when can generic versions of Bupivacaine Hydrochloride Preservative Free launch?
Bupivacaine Hydrochloride Preservative Free is a drug marketed by Eugia Pharma, Hikma Pharms, Intl Medicated, and Steriscience Speclts. and is included in four NDAs.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE is bupivacaine hydrochloride. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bupivacaine Hydrochloride Preservative Free
A generic version of BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE was approved as bupivacaine hydrochloride by HOSPIRA on February 17th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE?
- What are the global sales for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE?
- What is Average Wholesale Price for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE?
Summary for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 5 |
| Clinical Trials: | 55 |
| DailyMed Link: | BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE at DailyMed |
Recent Clinical Trials for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hartford Hospital | Phase 4 |
| University of Calgary | Phase 4 |
| Alberta Hip and Knee Clinic | Phase 4 |
See all BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE clinical trials
Pharmacology for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
| Drug Class | Amide Local Anesthetic |
| Physiological Effect | Local Anesthesia |
